I’m very excited to announce today the acceptance of our paper to ACS Central Science on “Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies”. I am proud to have lead the investigation of this truly collaborative effort where we show that nanomedicines have the potential to be a viable treatment for brain cancer patients.

In this paper we have gained a deeper fundamental insight into the mechanism of uptake and delivery of nanomedicines in diseased brain tissue. I’m proud of this work, but even prouder that we are taking this to the next step. Stay tuned!

Read the article here.